pharma · cystic fibrosis · Relapsing Multiple Sclerosis (relapsing-remitting, relapsing-progressive)
Théa Pharma Ireland
Verona Pharma Ireland Limited
Verona Pharma Ireland is a pharma organization headquartered in GB. Primary therapeutic focus areas include cystic fibrosis, Relapsing Multiple Sclerosis (relapsing-remitting, relapsing-progressive), multifocal spasticit
Castlebar, IE HQ
2018 Founded
19 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Castlebar, IE
- Founded
- 2018
- Employees
- 19
- Programs
- 11
- Drugs
- 42
- Patents
- 0
GR-2021-12373041
Approved · small molecule · patients with secondary progressive MS
GR-2021-12373041 for patients with secondary progressive MS is a Approved program (small_molecule) at Verona Pharma Ireland Limited with 1 ClinicalTrials.gov record(s).
Internal code GR-2021-12373041
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Verona Pharma Ireland Limited
- Phase
- Approved
- Modality
- small_molecule
- Indication
- patients with secondary progressive MS
- Status
- active
- Trials
- 1